Ontario Genomics Institute to Invest $87K in Amorfix to Support Development of Alzheimers Dx | GenomeWeb

NEW YORK, Jan. 31 (GenomeWeb News) - The Ontario Genomics Institute will invest Can$100,000 (US$87,465) in Amorfix Life Sciences to support development of a blood test for Alzheimer's disease, the organizations said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.